Connect with us

Healthcare

Over 205k crossed the border in July, the most reported since 2000

Published

on

sara carter border

[brid autoplay=”true” video=”835861″ player=”23886″ title=”Sick%20Migrants%20Cross%20Southern%20Border%20Exhibiting%20COVID%20Symptoms” duration=”311″ description=”undefined” uploaddate=”2021-07-29″ thumbnailurl=”//cdn.brid.tv/live/partners/18168/thumb/835861_t_1627544058.png” contentUrl=”//cdn.brid.tv/live/partners/18168/sd/835861.mp4″]


By Jenny Goldsberry

The United States Border Patrol released preliminary immigration numbers Monday. So far it’s the largest monthly encounter since the year 2000.

First, USBP reported 205,029 encounters at the southern border. Then the number of known got-aways at 37,400.

“It’s time to draw a line in the sand, for the sake of our country, our communities, our kids, and those who seek to come here,” Rep. Chip Roy (R-TX) tweeted. “It’s time to impeach [Department of Homeland Security Secretary Alejandro Mayorkas] for failing to uphold immigration law, enforce Title 42, and secure our border.” 

Roy also tweeted a breakdown of encounters at each sector across the state of Texas. However his own district isn’t even one of the border districts there.

Meanwhile, sick migrants have crossed the border with ease. According to Roy, thousands of Border Patrol officers contracted the virus and 33 died as a result. The latest report claims 400 active cases of coronavirus among migrants in La Joya, Texas alone. Immigration and Customs Enforcement reported over 1,200 COVID-positive migrants in custody last week.

However, Texas Governor Abbott is doing everything possible to stop the rising immigration. He recently ordered the Texas National Guard to action, having them make arrests at the border.

You can follow Jenny Goldsberry on Twitter @jennyjournalism.

You may like

Continue Reading

China

FDA will work with China to import cancer drugs due to U.S. shortages

Published

on

FinalFDAshutterstock 1044596995

Earlier this week the United States Food and Drug Administration (FDA) announced it will be working to import chemotherapy drugs from, of all places, China. The drug, called Cisplatin, is to help “ramp up supply amidst rampant drug shortages in the U.S.” reports Foreign Desk News.

Foreign Desk News writes:

Cisplatin comes from drugmaker Qilu Pharmaceutical, which is marketed and produced in China but has not been approved by the FDA. According to a May 24 letter, Qilu will work with the Canadian-based drug company Apotex to import and distribute the medication, which will come in 50-milligram vials with Chinese labels.

“The FDA is responding to yet another generic drug shortage,” said Edmund F. Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation. “The underlying cause of those shortages is that generic drugs have become low-margin commodity products,” he added.

Last week on Twitter, FDA commissioner Dr. Robert Califf said the partnership with Qilu Pharmaceutical is temporary but will provide patients with a potentially life-extending drug.

“The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” Califf said.

Foreign Desk News adds:

The latest move by the FDA is sure to spark concern and debate in Congress, as lawmakers in the House and Senate have called on the Biden administration to de-couple the U.S. economy from the Chinese markets, given Beijing’s aggressive push to expand in the South-China Sea and eventually take over the island state of Taiwan. China has also spread illegal and dangerous synthetic opioids and fentanyl drugs across the U.S. southern border, resulting in the devastating deaths of many Americans.

 

You may like

Continue Reading
Advertisement
-->

Trending Now

Advertisement
-->

Trending